Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

PCOS increases sexual pain distress in infertile women.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Vitamin E can reduce the negative effects of valproic acid on hair and skin development.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.